Icodextrin Peritoneal Dialysis Solution + Hypertonic Dextrose solution
ApprovedRecruiting 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Peritoneal Dialysis
Conditions
Peritoneal Dialysis
Trial Timeline
May 24, 2023 โ Dec 31, 2025
NCT ID
NCT05721404About Icodextrin Peritoneal Dialysis Solution + Hypertonic Dextrose solution
Icodextrin Peritoneal Dialysis Solution + Hypertonic Dextrose solution is a approved stage product being developed by Baxter for Peritoneal Dialysis. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05721404. Target conditions include Peritoneal Dialysis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05721404 | Approved | Recruiting |
Competing Products
20 competing products in Peritoneal Dialysis